NCT00041379View on ClinicalTrials.gov

Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia

PHASE1/PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

March 31, 2002

Conditions
Lymphoma
Interventions
DRUG

beta alethine

Trial Locations (1)

20852

Victory Over Cancer, Rockville

Sponsors
All Listed Sponsors
lead

LifeTime Pharmaceuticals

INDUSTRY

NCT00041379 - Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia | Biotech Hunter | Biotech Hunter